Skip to main content
AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
4.300
-0.140 (-3.15%)
Nov 13, 2026, 11:13 AM EST - Market open

AN2 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1633141609185-
Market Cap Growth
397.56%-24.24%-93.23%229.57%--
Enterprise Value
99-31-5248681-
Last Close Price
4.441.141.3820.499.53-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.230.590.504.891.94-
P/TBV Ratio
2.230.590.504.891.94-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.00-
Net Debt / Equity Ratio
-0.85-1.09-1.02-0.86-1.01-0.95
Quick Ratio
10.386.768.207.7413.3717.25
Current Ratio
10.486.878.437.8713.7217.70
Return on Equity (ROE)
-51.34%-52.14%-49.69%-58.83%-52.08%-66.64%
Return on Assets (ROA)
-31.37%-30.93%-29.54%-36.07%-31.47%-38.77%
Return on Capital Employed (ROCE)
-49.50%-71.60%-66.70%-55.80%-44.30%-34.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.88%-112.60%-124.47%-10.62%-22.15%-
Buyback Yield / Dilution
-29.10%-1.30%-26.39%-53.85%-481.46%-2.71%
SEC Filings: 10-K · 10-Q